Oxygenated End-Hypothermic Machine Perfusion in Expanded Criteria Donor Kidney Transplant: A Randomized Clinical Trial.
Husen P. et al, (2021), JAMA Surg
Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT.
Gathercole R. et al, (2021), Health Technol Assess, 25, 1 - 156
Efficacy of surgical masks or cloth masks in the prevention of viral transmission: Systematic review, meta-analysis, and proposal for future trial.
Nanda A. et al, (2021), J Evid Based Med
Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3, superiority trial.
Jochmans I. et al, (2020), The Lancet
Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.
Sathianathen NJ. et al, (2020), Eur Urol
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452
Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.
Bryant RJ. et al, (2019), J Urol, 201, 510 - 519
Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.
Hamdy FC. et al, (2018), Health Technol Assess, 22, 1 - 96
Prostatic capsular incision during radical prostatectomy has important oncological implications: a systematic review and meta-analysis.
Philippou Y. et al, (2018), BJU Int
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial.
Friedlander M. et al, (2018), Lancet Oncol, 19, 1126 - 1134
THE PART TRIAL - A PHASE III STUDY COMPARING PARTIAL PROSTATE ABLATION VERSUS RADICAL PROSTATECTOMY (PART) IN INTERMEDIATE RISK PROSTATE CANCER - EARLY DATA FROM THE FEASIBILITY STUDY
Leslie T. et al, (2017), JOURNAL OF UROLOGY, 197, E1118 - E1119